miR-17-5p promotes neoangiogenesis in NPC by downregulating bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and regulating AKT/vascular endothelial growth factor A (VEGF-A) signaling (Duan et al., 2019). This evidence concerns the gene VEGFA and nasopharyngeal carcinoma.